Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引：7
|
作者：
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构：
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
来源：
THORAX | 2013年 / 68卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I：
10.1136/thoraxjnl-2012-202483
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [41] Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma
    Villa-Roel, Cristina
    Borgundvaag, Bjug
    Majumdar, Sumit R.
    Emond, Marcel
    Campbell, Sam
    Sivilotti, Marco
    Abu-Laban, Riyad B.
    Stiell, Ian G.
    Aaron, Shawn D.
    Senthilselvan, Ambikaipakan
    Rowe, Brian H.
    JOURNAL OF ASTHMA, 2019, 56 (09) : 985 - 994
  • [42] A Brief Report on a Systematic Review of Real-World Effectiveness Studies of ICS/LAMA/LABA for Treatment of Adults with Asthma in the US
    Noorduyn, Stephen G.
    Begaj, Kejsi
    Martin, Amber
    Forero-Schwanhaeuser, Sergio
    Schaible, Kassandra
    Moore, Alison
    Paczkowski, Rosirene
    PULMONARY THERAPY, 2025, : 159 - 176
  • [43] Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma
    Mukhopadhyay, Aniruddha
    Waked, Mirna
    Gogtay, Jaideep
    Gaur, Vaibhav
    RESPIRATORY MEDICINE, 2020, 170
  • [44] Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?
    Buhl, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S381 - S385
  • [45] POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes
    Cazzola, Mario
    Matera, Maria Gabriella
    CHEST, 2018, 154 (04) : 746 - 748
  • [46] Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting β-agonist inhaler therapy in asthma
    Perrin, Kyle
    Williams, Mathew
    Wijesinghe, Meme
    James, Kate
    Weatherall, Mark
    Beasley, Richard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (03) : 505 - 510
  • [47] Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study
    Bogart, Michael
    Stanford, Richard H.
    Reinsch, Tyler
    Hull, Michael
    Buikema, Ami
    Hulbert, Erin
    RESPIRATORY MEDICINE, 2018, 142 : 73 - 80
  • [48] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Akira Koarai
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Hisatoshi Sugiura
    Respiratory Research, 22
  • [49] Salmeterol/fluticasone propionate combination inhaler: A convenient and effective therapy for persistent asthma
    不详
    Drugs & Therapy Perspectives, 2001, 17 (17) : 1 - 5
  • [50] Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    RESPIRATORY MEDICINE, 2021, 189
12345